JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today announced the Office of the Chief Executive Officer, which will now include George Barrett, President & CEO, Teva North America; and Amir Elstein, Vice President, Global Specialty Pharmaceutical Products. Mr. Barrett will assume the additional role of Executive Vice President, Global Pharmaceutical Markets, and Mr. Elstein will assume the additional role of Executive Vice President, Global Resources. The goal of the office is to more effectively align the Company’s operations with its corporate strategy to solidify Teva’s market leadership in a rapidly evolving global healthcare industry.
